Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × Vinorelbine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 9 Neoplasm Metastasis 6 Hodgkin Disease 6 Neoplasms 4 Recurrence 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Mesothelioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Carcinoma 2 Breast Neoplasms, Male 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Pleural Effusion, Malignant 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non - Small Cell Lung Cancer NSCLC 1 Neuroendocrine Tumors 1 Neuralgia 1 Metatropic dwarfism 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Locally Advanced Non-Small Cell Lung Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Desmoplastic Small Round Cell Tumor 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡